Bhargava named CC@IL director, awarded $1.6M NIH grant

6/16/2016

Rohit Bhargava will begin a three-year term as the director of the Cancer Community @ Illinois.

Written by

Rohit Bhargava, ECE Affiliate Faculty member, professor in the Department of Bioengineering, member of Beckman’s Bioimaging Science and Technology Group, and Abel Bliss Scholar at Illinois, has been named director of the Cancer Community @ Illinois (CC@IL) for a three-year term.

Rohit Bhargava
Rohit Bhargava
Bhargava has experience leading the CC@IL, having served as faculty coordinator for the past four years. As director, he will spearhead efforts to unite researchers in the effort to find better ways to prevent, detect, diagnose, and treat cancer.

Earlier this year, the National Cancer Institute (NCI) of the National Institutes of Health (NIH) awarded a grant totalling more than $1.6M to Bhargava and Beckman researchers in his lab. 3D Prostate Histochemometry to Predict Disease Recurrence proposes a new chemical imaging technology to determine the risk of lethal prostate cancer upon initial diagnosis, with the goal of preventing over-treatment.


Share this story

This story was published June 16, 2016.